In a move that could have major global implications, the European Union (EU) is considering classifying ethanol—the active ingredient in most hand sanitisers—as a carcinogenic and reproductive toxicant. This potential reclassification by the European Chemicals Agency (ECHA) has triggered widespread debate across the scientific community, public-health sectors, and the sanitiser manufacturing industry.
While no final decision has yet been made, the possibility of ethanol being labelled as hazardous raises fundamental questions about the future of hygiene products, hospital disinfection standards, and even post-pandemic consumer safety norms.
Ethanol Under the Microscope
According to reports from the Financial Times and Reuters, the ECHA’s internal committee recently proposed reviewing ethanol’s safety classification under the EU’s Biocidal Products Regulation (BPR). The Biocidal Products Committee (BPC), which evaluates the safety of chemicals used in disinfectants and hygiene products, is expected to hold a detailed review session between November 25 and 28, 2025.
If the BPC concludes that ethanol meets the criteria for carcinogenicity or reproductive toxicity—categories known as CMR (Carcinogenic, Mutagenic, or Reproductive toxicant)—it could lead to restrictions on its use across multiple industries. The European Commission would then make the final decision based on the committee’s findings.
Currently, ethanol remains approved for use in personal hygiene products such as hand sanitisers and medical disinfectants, which are essential tools in infection control and disease prevention.
Why the Move Is Controversial
Ethanol is not a niche substance—it is one of the most commonly used disinfectants worldwide. During the COVID-19 pandemic, ethanol-based sanitisers became a first line of defence in both public spaces and hospitals. Typically, hand sanitisers contain between 60–80% ethanol, a concentration proven to effectively kill viruses, bacteria, and fungi.
Critics of the proposed classification argue that ethanol exposure from hand sanitisers is not equivalent to ethanol exposure through alcohol consumption, which has long been linked to cancer risks, particularly of the mouth, throat, liver, and breast.
The concern arises because, under the BPR, even a partial carcinogenic classification would require ethanol-based products to carry stricter hazard labels or face restrictions. This could have a ripple effect, forcing hospitals, schools, and businesses to reformulate or replace ethanol-based disinfectants—potentially with less effective or more expensive alternatives.
The Scientific Evidence So Far
From a toxicological standpoint, ethanol is known to pose health risks when ingested in significant quantities, as in alcoholic beverages. However, multiple peer-reviewed studies have shown that dermal exposure (through skin contact) and inhalation (from sanitiser vapours) lead to negligible absorption levels in the bloodstream.
A review published by the U.S. National Library of Medicine notes that there is no strong epidemiological evidence linking the normal use of ethanol-based hand rubs to cancer or reproductive harm in humans. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) both continue to endorse ethanol-based sanitisers as safe and essential for infection control.
Still, the EU’s regulatory stance is based on a “precautionary principle”—which means that even a theoretical risk could justify stricter labelling, especially if long-term exposure scenarios cannot be fully ruled out.
Potential Consequences of a New Classification
If ethanol is eventually classified as a Category 1A or 1B carcinogen, the impact would be far-reaching:
- Manufacturers would be required to redesign or reformulate products, possibly substituting ethanol with isopropanol or other chemicals.
- Hospitals and clinics, which depend heavily on ethanol-based sanitisers for rapid hand hygiene, might face supply disruptions and increased costs.
- Consumers could see warning labels indicating potential reproductive or carcinogenic risks, even though actual risk remains extremely low at practical exposure levels.
- Exporting countries, including India, could face tighter compliance requirements for products shipped to or sold within the EU.
Such changes might also influence global health guidelines. For instance, India’s Central Drugs Standard Control Organization (CDSCO) and the Bureau of Indian Standards (BIS) could be compelled to revisit their own product safety frameworks if the EU adopts new norms.
Balancing Safety and Public Health
Public-health experts warn that excessive caution might create unintended risks. Ethanol is valued for its broad antimicrobial spectrum, quick evaporation, and relatively mild toxicity profile. If hospitals are forced to switch to weaker or more irritating chemicals, the effectiveness of infection control could decline—potentially leading to higher rates of hospital-acquired infections.
“Ethanol-based rubs are the gold standard in healthcare,” said a European infectious-disease expert quoted by FT. “Replacing them without equally effective alternatives could do more harm than good.”
Meanwhile, advocates of the review argue that transparency and updated scientific evaluations are necessary. “Consumers deserve to know the full safety profile of the chemicals they use daily,” one environmental health researcher noted. “A review doesn’t automatically mean a ban—it’s about ensuring accountability.”
What Happens Next
The ECHA’s Biocidal Products Committee will assess the toxicological, epidemiological, and occupational exposure data before issuing a recommendation later this year. If the committee votes for reclassification, the European Commission will hold a public consultation and may take up to a year to formalise new rules.
That means any change in ethanol’s regulatory status would likely not take effect until late 2026 or 2027—if at all. Until then, ethanol-based sanitisers remain fully legal and considered safe for everyday use.
The Global Ripple Effect
Beyond Europe, the decision could trigger a domino effect in other markets. Countries that align their chemical safety standards with the EU—such as the UK, Australia, and parts of Asia—may follow suit, reshaping the global disinfectant market.
For India, a major producer and exporter of ethanol-based hygiene products, this could mean significant economic and regulatory challenges. Domestic manufacturers may have to invest in new testing protocols, labelling systems, or product reformulation, even if the actual health risks remain minimal.
A Question of Perspective
At this stage, ethanol’s potential reclassification as a carcinogenic substance remains a proposal, not a policy. The debate underscores a complex dilemma at the intersection of science, public health, and regulation: how to balance theoretical risks against proven benefits.
For now, health experts maintain that ethanol-based sanitisers are safe, effective, and irreplaceable in infection control. Consumers are advised not to alter their hygiene habits—hand hygiene remains one of the most effective defences against infectious disease.
But as the EU moves forward with its review, the outcome could redefine how the world perceives and regulates one of humanity’s oldest and most trusted disinfectants.
About The Author
